- Home
- ONVO vs BMRA Comparison
ONVO vs BMRA Comparison
Compare ONVO & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONVO
- BMRA
- Stock Information
- Founded
- ONVO 2007
- BMRA 1971
- Country
- ONVO United States
- BMRA United States
- Employees
- ONVO N/A
- BMRA N/A
- Industry
- ONVO Biotechnology: Biological Products (No Diagnostic Substances)
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- ONVO Health Care
- BMRA Health Care
- Exchange
- ONVO Nasdaq
- BMRA Nasdaq
- Market Cap
- ONVO 7.2M
- BMRA 7.4M
- IPO Year
- ONVO N/A
- BMRA N/A
- Fundamental
- Price
- ONVO $0.42
- BMRA $0.33
- Analyst Decision
- ONVO
- BMRA
- Analyst Count
- ONVO 0
- BMRA 0
- Target Price
- ONVO N/A
- BMRA N/A
- AVG Volume (30 Days)
- ONVO 102.4K
- BMRA 337.1K
- Earning Date
- ONVO 11-26-2024
- BMRA 10-15-2024
- Dividend Yield
- ONVO N/A
- BMRA N/A
- EPS Growth
- ONVO N/A
- BMRA N/A
- EPS
- ONVO N/A
- BMRA N/A
- Revenue
- ONVO $103,000.00
- BMRA $5,509,000.00
- Revenue This Year
- ONVO $59.08
- BMRA N/A
- Revenue Next Year
- ONVO $18.24
- BMRA N/A
- P/E Ratio
- ONVO N/A
- BMRA N/A
- Revenue Growth
- ONVO N/A
- BMRA 1.74
- 52 Week Low
- ONVO $0.32
- BMRA $0.24
- 52 Week High
- ONVO $1.74
- BMRA $2.13
- Technical
- Relative Strength Index (RSI)
- ONVO 47.62
- BMRA 45.05
- Support Level
- ONVO $0.39
- BMRA $0.34
- Resistance Level
- ONVO $0.46
- BMRA $0.44
- Average True Range (ATR)
- ONVO 0.05
- BMRA 0.04
- MACD
- ONVO -0.00
- BMRA -0.00
- Stochastic Oscillator
- ONVO 62.27
- BMRA 23.21
About ONVO Organovo Holdings Inc.
Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.